Literature DB >> 29399349

Atypical spleen tuberculosis in a melanoma patient accidentally detected during a 18F-FDG PET/CT study: Case report.

Paulina Cegla1, Arkadiusz Spychala2, Andrzej Marszalek3, Ewa Wierzchoslawska4, Witold Cholewinski5.   

Abstract

The present study, discussed a rare case of a 50-year-old woman who was treated for malignant melanoma and underwent 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) examination for evaluation of disease. 18F-FDG-PET/CT examination was performed from the top of the head down to the knee using a Gemini TF PET/CT scanner 60 min following intravenous injection of radiotracer with mean activity of 364±75 MBq. Previous performed laboratory test and clinical examination was irrelevant. By abdominal ultrasound no abnormalities in abdominal organs beside the liver cyst were found. The 18F-FDG PET/CT exam showed an increased glucose metabolism in the anterior pole of the spleen, which was considered as melanoma metastasis. Splenectomy was performed and histopathology examination tuberculous lesion in the spleen was revealed. Histopathology examination showed epithelioid granuloma and in correlation with the patient's history allowed to establish tuberculous-like lesions in the spleen. In the present study, authors used 18F-FDG PET/CT examination to detect the melanoma metastasis of a 50-year-old woman, and found that abnormal focal accumulation of radiotracer with limited cancer specificity in PET/CT examination in cancer patients should not be unambiguously taken as a metastatic lesion.

Entities:  

Keywords:  18F-FDG-PET/CT; CT; MRI; SUVmax; USG; malignant melanoma; nuclear medicine; spleen; spleen tuberculosis

Year:  2017        PMID: 29399349      PMCID: PMC5772677          DOI: 10.3892/mco.2017.1498

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  11 in total

1.  Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.

Authors:  F Crippa; M Leutner; F Belli; F Gallino; M Greco; S Pilotti; N Cascinelli; E Bombardieri
Journal:  J Nucl Med       Date:  2000-09       Impact factor: 10.057

Review 2.  Imaging of the spleen: what the clinician needs to know.

Authors:  T Vancauwenberghe; A Snoeckx; D Vanbeckevoort; S Dymarkowski; F M Vanhoenacker
Journal:  Singapore Med J       Date:  2015-03       Impact factor: 1.858

3.  Non FDG PET.

Authors:  C Nanni; L Fantini; S Nicolini; S Fanti
Journal:  Clin Radiol       Date:  2010-07       Impact factor: 2.350

4.  Unusual presentation of tuberculosis as a splenic mass.

Authors:  Fatih Dede; Elvin Doğan; Mehmet Demir; Didem Sener; Mehmet Kös; Murat Tad; Erdal Eskioğlu
Journal:  Tohoku J Exp Med       Date:  2006-09       Impact factor: 1.848

5.  Splenic Tuberculosis--Case Report.

Authors:  Călin Cobelschi; Adrian Maier; Mircea Daniel Hogea; Alen Redalf Alfred Gheorghiu; Iulian Toader
Journal:  Chirurgia (Bucur)       Date:  2016 Mar-Apr

6.  Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.

Authors:  Yan Xing; Yulia Bronstein; Merrick I Ross; Robert L Askew; Jeffrey E Lee; Jeffrey E Gershenwald; Richard Royal; Janice N Cormier
Journal:  J Natl Cancer Inst       Date:  2010-11-16       Impact factor: 13.506

Review 7.  (18)F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis.

Authors:  Powell Perng; Charles Marcus; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2015-08       Impact factor: 3.959

8.  Tuberculosis of spleen presenting with pyrexia of unknown origin in a non-immunocompromised woman.

Authors:  Prem Parkash Gupta; Sanjay Fotedar; Dipti Agarwal; Pradeep Sansanwal
Journal:  Lung India       Date:  2008-01

Review 9.  Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.

Authors:  Bruno Krug; Ralph Crott; Max Lonneux; Jean-François Baurain; Anne-Sophie Pirson; Thierry Vander Borght
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

Review 10.  F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review.

Authors:  Milly A Schröer-Günther; Robert F Wolff; Marie E Westwood; Fülöp J Scheibler; Christoph Schürmann; Brigitta G Baumert; Stefan Sauerland; Jos Kleijnen
Journal:  Syst Rev       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.